Tumor radiosensitization with concomitant vone marrow radioprotection: A study in mice using diethyldithiocarbamate (DDC) under oxygenated and hypoxic conditions

International Journal of Radiation Oncology, Biology, Physics

Volumn 11, Issue 6, 1985, Pages 1163-1169

  Evans, Richard G ^a  

^a MAYO CLINIC   (United States)

Author keywords

DDC; Radioprotection; Radiosensitization

Indexed keywords

AMIFOSTINE; DIETHYLDITHIOCARBAMIC ACID;

ANIMAL MODEL; BLOOD AND HEMOPOIETIC SYSTEM; BONE MARROW; CANCER GRAFT; DRUG EFFICACY; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION PROTECTION; RADIOSENSITIZATION; RIF SARCOMA;

ANIMAL; BONE MARROW; DITIOCARB; MALE; MICE; MICE, INBRED C3H; NEOPLASMS, EXPERIMENTAL; OXYGEN; RADIATION-PROTECTIVE AGENTS; RADIATION-SENSITIZING AGENTS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; THIOCARBAMATES;

EID: 0021866685     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/0360-3016(85)90065-3     Document Type: Article

References (33)

1. Colony forming units and survival of irradiated mice treated with AET or endotoxin
2. Evaluation of diethyldithiocarbamate as a radioprotector of vone marrow
3. Clinical trials of WR-2721 with radiation therapy
4. X-radiation (cell survival, regrowth delay, and tumor control), chemotherapeutic agents and activated macrophages
5. Radioprotection of mouse skin by WR-2721 The critical influence of oxygen tension
6. Thiol radioprotection in vivo: The critical role of tissue oxygen concentration
7. Radioprotection by WR-2721 in vitro at low oxygen tensions: Implications for its mechanism of action
8. Modification of the sensitivity and repair of potentially lethal damage by diethyldithiocarbamate (DDC) during and following exposure of plateau-phase cultures of mammalian cells to radiation and cis-Diamminedichloroplatinum (II)
9. An in vivo study of the radioprotective effect of diethyldithiocarbamate (DDC)
10. Enhancement of heat sensitivity and modification of repair of potentially lethal damage in plateau-phase cultures of mammalian cells by diethyldithiocarbamate
11. Enhancement of the therapeutic effect of cis-platinum by DDC A study in lymphoma-bearing mice
12. Modification of the vone marrow toxicity of cis-Diamminedichloroplatinum (II) in mice by diethyldithiocarbamate (DDC)
13. Phase I clinical trials of WR-2721 with alkylating agent chemotherapy
14. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy
15. Repair of potentially lethal lesions in X-irradiated, denselyinhibited Chinese hamster cells: Metabolic effects and hypoxia
16. Quantitation of the radiotherapeutic importance of naturally-hypoxic normal tissues from collated experiments with rodents using single doses
17. On the relative importance of hypoxic cells for the radiotherapy of human tumors
18. Diethyldithiocarbamate enhancement of radiation and hyperthermic effects on Chinese hamster cells in vitro
19. A simplified method of evaluating dose-effect experiments
20. A cautionary note on the use of thiol compounds to protect normal tissues in radiotherapy
21. In vivo radioprotection of normal tissues and a tumor by diethyldithiocarbamate (DDC)
22. Low radioprotection by thiol in lung: The role of local tissue oxygenation
23. Radioprotection of mouse skin vasculature and the RIF-1 fibrosarcoma by WR-2721
24. Superoxide dismutase and glutathione peroxidase activities in tumors
25. Qualitative alteration in radiation injury under hypoxic conditions
26. Combined chemical and hypoxic protection against whole body X irradiation in the nestling rat
27. The treatment of acute nickel-carvonyl poisoning with sodium Diethyldithiocarbamate
28. A direct measurement of the radiosensitivity of normal mouse vone marrow cells
29. A new mouse tumor model system RIF-1 for comparison of end-point studies
30. Chemical aspects of DNA radioprotection
31. Diethyldithiocarbamate (DDC), a superoxide dismutase inhibitor, decreases the radioresistance of Chinese hamster cells
32. Clinical trial of the effect of S-2-(3-Aminopropylamino)ethylphosphorothioic Acid (WR-2721) on the toxicity of cyclophosphamide
33. Active versus passive absorption kinetics as the basis for selective protection of normal tissues by WR-2721